TNFRSF10B and B-cell chronic lymphocytic leukemia: This difference in receptor oligomerization between DR4 and DR5 required for apoptosis induction has also been reported with specific antibodies directed against each receptor on chronic lymphocytic leukemia, where cross-linking of anti-DR5 via a secondary antibody was necessary to efficiently kill the cells [18].